References
- World Health Organization. Hepatitis B. [Internet]. 2024 [Accessibility date: 25 August 2024]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
- Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023 Aug;20(8):524-537. DOI: 10.1038/s41575-023-00760-9
- Ezer B, Ozdemir M. Relationship of serum hepatitis B Virus DNA levels with Hepcidin, Pentraxin-3, Zonulin, and Copeptin in chronic hepatitis B patients. J Infect Dev Ctries. 2025;19:615-622. DOI: 10.3855/jidc.20918
- Croagh CM, Lubel JS. Natural history of chronic hepatitis B: phases in a complex relationship. World J Gastroenterol. 2014 Aug; 20(30):10395-404. DOI: 10.3748/wjg.v20.i30.10395
- Yao QY, Feng YD, Han P, Yang F, Song GQ. Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients. World J Gastroenterol. 2020 Jul 21;26(27):3917-28. DOI: 10.3748/wjg.v26.i27.3917
- Hamidi AA, Oncul A, Ozguven BY, Sevgi DY, Gunduz A, Uzun N, et al. Diagnostic accuracy of different noninvasive scores for detecting advanced fibrosis in chronic hepatitis B. Eur J Gastroenterol Hepatol. 2019 Nov;31(11):1439-43. DOI: 10.1097/MEG.0000000000001428
- Shen J, Dai S, Huang Y, Fan X, Zhao S, Wang Z. Correlation between related inflammation indicators and the degree of liver fibrosis in patients with chronic hepatitis B. Medicine. 2025 Aug;104(31):e43545. DOI: 10.1097/MD.0000000000043545
- Aaldijk AS, Verzijl CRC, Jonker JW, Struik D. Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho. Front Endocrinol . 2023 May 16;14:1150222. DOI: 10.3389/fendo.2023.1150222
- Fang C, Miao X, Peng C, Xie Z, Zhao F, Chen T, et al. Serum β-klotho is a potential biomarker for diagnosing alcoholic liver disease and differentiating from nonalcoholic fatty liver disease. Peer J. 2025 Aug 6;13:e19779. DOI: 10.7717/peerj.19779
- Ogawa Y, Kurosu H, Yamamoto M, Nandi A, Rosenblatt KP, Goetz R, et al. Beta Klotho is required for metabolic activity of fibroblast growth factor 21. Proc Natl Acad Sci U S A. 2007 May 1;104(18):7432-7. DOI: 10.1073/pnas.0701600104
- Kaur N, Gare SR, Shen J, Raja R, Fonseka O, Liu W. Multi-organ FGF21-FGFR1 signaling in metabolic health and disease. Front Cardiovasc Med. 2022 Aug 2;9:962561. DOI: 10.3389/fcvm.2022.962561
- Chu Y, Yang S, Chen X. Fibroblast growth factor receptor signaling in metabolic dysfunction-associated fatty liver disease: Pathogenesis and therapeutic targets. Pharmacol Ther. 2025 May;269:108844. DOI: 10.1016/j.pharmthera.2025.108844
- Lee KJ, Jang YO, Cha SK, Kim MY, Park KS, Eom YW, et al. Expression of Fibroblast Growth Factor 21 and β-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-κB and c-Jun N-Terminal Kinase Pathways. Gut Liver. 2018 Jul 15;12(4):449-456. DOI: 10.5009/gnl17443
- Dongiovanni P, Crudele A, Panera N, Romito I, Meroni M, De Stefanis C, et al. β-Klotho gene variation is associated with liver damage in children with NAFLD. J Hepatol. 2020 Mar;72(3):411-419. DOI: 10.1016/j.jhep.2019.10.011
- Miao X, Peng C, Yan F, Guo X, Xia L, Song Q, et al. Serum β-klotho is a potential biomarker for the progression of hepatitis B virus-related liver diseases. J Infect Dev Ctries. 2024 Apr 30;18(4):618-626. DOI: 10.3855/jidc.17870
- Hong H, Han X, Hu Q, Song H, Han B. Identification and evaluation of biomarkers for diagnosis of chronic hepatitis B using RNA-seq. Virus Res. 2025 Aug;358:199589. DOI: 10.1016/j. virusres.2025.199589
- Yuan J, Chen J, Su H, Chen Y, Han T, Chen T, et al. The Predictive Role of the Systemic Inflammation Response Index in the Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure: A Multicenter Study. Healthcare. 2025;13:2199. DOI 10.3390/healthcare13172199 DOI: 10.3390/healthcare13172199
- Lemoine M, Shimakawa Y, Nayagam S, Khalil M, Suso P, Lloyd J, et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut. 2016 Aug;65(8):1369-76. DOI: 10.1136/gutjnl-2015-309260
- Kuro-o M. Klotho and aging. Biochim Biophys Acta. 2009 Oct;1790(10):1049-58. DOI: 10.1016/j.bbagen.2009.02.005
- Hu MC, Shi M, Zhang J, Quiñones H, Griffith C, Kuro-o M, et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2011 Jan;22(1):124-36. DOI: 10.1681/ASN.2009121311
- Haoqi Chen, Xiaolong Chen, Genshu Wang. Platelets: A review of their function and effects in liver diseases. Liver Research. 2020;4(3):129-135. DOI: 10.1016/j.livres.2020.08.002
- Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006 Jun;43(6):1317-25. DOI: 10.1002/hep.21178
- Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W,et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014 Dec 1;20(23):6212-22. DOI: 10.1158/1078-0432.CCR-14-0442
- Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5-14. PMID: 11723675.
- Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, Park JY,et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int. 2007 Sep;27(7):969-76. DOI: 10.1111/j.1478-3231.2007.01519.x
- Zhao X, Han D, Zhao C, Yang F, Wang Z, Gao Y,et al. New insights into the role of Klotho in inflammation and fibrosis: molecular and cellular mechanisms. Front Immunol. 2024 Sep 6;15:1454142. DOI: 10.3389/fimmu.2024.1454142
- Ezer B, Esen HS, Ugrakli S, Iyisoy MS, Ozdemir M. Association Between Serum HBV DNA Levels and CCL-20, CD8a, CXCL-16, and GDF-15 in Patients with Chronic Hepatitis B. Viruses. 2025 Oct 8;17(10):1352. DOI: 10.3390/v17101352